Log in to save to my catalogue

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individual...

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individual...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9873555

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

About this item

Full title

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2023-01, Vol.29 (1), p.270-278

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

In July 2022, the ongoing monkeypox (MPX) outbreak was declared a public health emergency of international concern. Modified vaccinia Ankara—Bavarian Nordic (MVA-BN, also known as Imvamune, JYNNEOS or Imvanex) is a third-generation smallpox vaccine that is authorized and in use as a vaccine against MPX. To date, there are no data showing MPX virus...

Alternative Titles

Full title

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9873555

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9873555

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-022-02090-w

How to access this item